絞り込み

17054

広告

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice.

著者 Czarnecka AM , Teterycz P , Mariuk-Jarema A , Lugowska I , Rogala P , Dudzisz-Sledz M , Switaj T , Rutkowski P
Target Oncol.2019 Nov 21 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

Miscellaneous

Although BRAF/MEK inhibitors are generally considered to be equally effective whether given before or after immunotherapy, no prospective trial has confirmed this hypothesis and contradictory data have been published in the melanoma field.
PMID: 31754963 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード